Kamalaksha, Sujatha <br/><br/>
Significance of combined anti-CCP antibodies and rheumatoid factor in a New Zealand cohort of patients with systemic sclerosis.  [electronic resource] 

 -  International journal of rheumatic diseases  Jul 2018 
 - 1430-1435 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1756-185X 
<br/><br/><label>Standard No.: </label>10.1111/1756-185X.13330  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Citrullinated Protein Antibodies--blood<br/>Antirheumatic Agents--therapeutic use<br/>Biomarkers--blood<br/>Female<br/>Humans<br/>Joint Diseases--blood<br/>Joints--diagnostic imaging<br/>Male<br/>Middle Aged<br/>New Zealand<br/>Peptides, Cyclic--immunology<br/>Prognosis<br/>Prospective Studies<br/>Rheumatoid Factor--blood<br/>Scleroderma, Systemic--blood<br/>Time Factors<br/>Young Adult